首页> 外文OA文献 >PMS24 THE COST EFFECTIVENESS OF STRONTIUM RANELATE VERSUS RISEDRONATE, RALOXIFENE, IBANDRONATE, ALENDRONATE AND CALCITONIN IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROTIC WOMEN IN TURKEY

【2h】

PMS24 THE COST EFFECTIVENESS OF STRONTIUM RANELATE VERSUS RISEDRONATE, RALOXIFENE, IBANDRONATE, ALENDRONATE AND CALCITONIN IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROTIC WOMEN IN TURKEY

机译：PMS24雷诺酸锶对利塞膦酸盐，雷洛昔芬，艾苯膦酸盐，阿仑膦酸盐和降钙素在土耳其绝经后骨质疏松症治疗中的成本效益

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Malhan S.; Cetin A.; Gur A.; Kavuncu V.; Tan M.;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Cost-effectiveness of strontium ranelate versus risedronate in the treatment of postmenopausal osteoporotic women aged over 75 years. [J] . Hiligsmann M, Bruyere O, Reginster JY Bone . 2010,第2期

机译：雷奈酸锶与利塞膦酸盐治疗75岁以上绝经后骨质疏松妇女的成本效益比较。
2. The clinical effectiveness and cost-effectiveness of strontium ranelate for the prevention of osteoporotic fragility fractures in postmenopausal women [J] . Health technology assessment: HTA . 2007,第4期

机译：雷奈酸锶预防绝经后妇女骨质疏松性骨折的临床疗效和成本效益
3. Cost-utility of long-term strontium ranelate treatment for postmenopausal osteoporotic women. [J] . Hiligsmann M, Bruyere O, Reginster JY Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA . 2010,第1期

机译：雷奈酸锶长期治疗绝经后骨质疏松妇女的成本效益。
4. Effect of Strontium Ranelate on Vertebral Pain Syndrome and quality of life in Postmenopausal Women: Results of a Multicenter Ukrainian Study [C] . Povoroznyuk V.V., Dzerovych N.I., Bondarenko LI., World Congress of Pain Clinicians . 2012

机译：锶ranelate对绝经后妇女椎体疼痛综合征和生活质量的影响：多中心乌克兰研究的结果
5. Alendronate and hormone replacement therapy in the prevention of osteoporotic fracture: A pharmacoeconomic analysis employing a net -benefit regression method of cost -effectiveness. [D] . Tiller, Kevin Wade. 2004

机译：阿仑膦酸盐和激素替代疗法在预防骨质疏松性骨折中的作用：药物经济学分析，采用成本效益的净效益回归方法。
6. Comparison of Monthly Ibandronate Versus Weekly Risedronate in Preference Convenience and Bone Turnover Markers in Korean Postmenopausal Osteoporotic Women [O] . Yoon-Sok Chung, Sung-Kil Lim, Ho-Yeon Chung, -1

机译：韩国绝经后骨质疏松症妇女在偏好便利性和骨转换指标上每月伊班膦酸与每周利森酸的比较
7. Comparison of monthly ibandronate versus weekly risedronate in preference, convenience, and bone turnover markers in Korean postmenopausal osteoporotic women. [O] . Chung, YS, Lim, SK, Chung, HY, 2010

机译：在韩国绝经后骨质疏松症妇女中，伊班膦酸月度和每周利塞膦酸的偏爱，便利性和骨转换指标的比较。

PMS24 THE COST EFFECTIVENESS OF STRONTIUM RANELATE VERSUS RISEDRONATE, RALOXIFENE, IBANDRONATE, ALENDRONATE AND CALCITONIN IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROTIC WOMEN IN TURKEY

著录项

相似文献

相关主题

期刊订阅